Aterian
ATN · Main Market · Basic Resources · mcap £4.6m · 23.5p
- Revenue
- £1.4m
- Operating profit
- −£1.5m
- Net income
- −£1.9m
- Free cash flow
- −£2.0m
- Net debt
- £1.1m
- Market cap
- £4.7m
- EV / EBIT
- –
- FCF yield
- −43.1%
- Price / book
- 2.6×
- Revenue
- £1.3m +6605%
- Operating profit
- −£324k prior −£658k
- Net income
- −£568k prior −£698k
- Cash from operations
- −£916k prior −£379k
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Every line as the company printed it, newest first – each period in the latest version the company published (restated figures where a later report restated them), in its own currency and units. Italic = calculated (H2 = full year − first half). The column headings link to the announcements.
Standardised line items in £m, comparable across companies; when a later report restated a period, the later figure is shown and marked r (hover for the figure first reported). Italic = calculated (LTM, H2 = FY − H1); a year of other than 12 months is marked (15m). Hover a value for its source.
Latest report: H1 26 (six months to 30 Jun 26), published 30 Sep 26 · read the results ↗
| FY 25£'000 source | FY 24£'000 source | |
|---|---|---|
| Group | ||
| Revenue | 110 | – |
| Cost of sales | (42) | – |
| Gross profit | - | – |
| Administrative expenses | (1,698) | – |
| Share-based payment expense | (102) | – |
| Disposal of net smelter royalty | 200 | – |
| Other income | 1 | – |
| Gains on disposal of property plant and equipment | 10 | – |
| Operating loss | (1,558) | – |
| Interest received | - | – |
| Gain on fair valued financial instruments | 33 | – |
| Interest payable and similar charges | (264) | – |
| Loss before tax | (1,617) | – |
| Tax expense | - | – |
| Loss after tax | (1,617) | – |
| Other comprehensive income | ||
| Items that may be reclassified to profit or loss | ||
| Loss on translation of foreign operations | (232) | – |
| Total comprehensive loss | (1,849) | – |
| Loss per share | ||
| Basic and diluted loss per share (pence) | (15.14) | – |
| All activities relate to continuing operations. | ||
| The accompanying notes are an integral part of these financial statements. | ||
| CONSOLIDATED AND COMPANY STATEMENT OF FINANCIAL POSITION | ||
| AS AT 31 DECEMBER 2025 | ||
| Group Company | ||
| Notes 31-Dec-25 31-Dec-24 31-Dec-25 31-Dec-24 | ||
| £'000 £'000 £'000 £'000 | ||
| Non-current assets | ||
| Investments | - | 3,241 |
| Intangible exploration and evaluation assets | 3,405 | - |
| Property, plant and equipment | 139 | 7 |
| Total non-current assets | 3,544 | 3,248 |
| Current assets | ||
| Trade and other receivables | 76 | 62 |
| Inventories | 17 | - |
| Cash and cash equivalents | 64 | 57 |
| Total current assets | 157 | 119 |
| Total assets | 3,701 | 3,367 |
| Equity and liabilities | ||
| Share capital | 11,006 | 11,006 |
| Share premium | 2,753 | 2,753 |
| Share-based compensation reserve | 2,482 | 2,482 |
| Interest in shares in EBT | (839) | (839) |
| Translation reserve | (656) | - |
| Accumulated losses | (13,647) | (14,543) |
| Convertible loan notes - equity component | 15 | 15 |
| Merger relief reserve | 1,200 | 1,200 |
| Total equity | 2,314 | 2,074 |
| Current liabilities | ||
| Trade and other payables | 560 | 466 |
| Provision for loss | 161 | 161 |
| Deferred consideration | - | - |
| Borrowings | 666 | 666 |
| Derivative liability | - | - |
| Total current liabilities | 1,387 | 1,293 |
| Non-current liabilities | ||
| Borrowings | - | - |
| Total non-current liabilities | - | - |
| Total liabilities | - | - |
| Total equity and liabilities | 3,701 | 3,367 |
| H1 26£'000 source | H2 25£'000 calc. | H1 25£'000 source | |
|---|---|---|---|
| Revenue | 1,341 | 90 | 20 |
| Cost of sales | (819) | (25) | (17) |
| Gross profit | 522 | (3) | 3 |
| Administrative expenses | (844) | (1,066) | (632) |
| Share-based payment expense | (2) | (72) | (30) |
| Other income | - | - | 1 |
| Operating loss | (324) | (900) | (658) |
| Loss on fair valued financial instruments | (151) | – | - |
| Interest payable and similar charges | (93) | (224) | (40) |
| Loss before tax | (568) | (919) | (698) |
| Tax expense | - | - | - |
| Loss after tax | (568) | (919) | (698) |
| Other comprehensive income | |||
| Items that may be reclassified to profit or loss | |||
| Gains on translation of foreign operations | 40 | – | 11 |
| Total comprehensive loss | (528) | (1,162) | (687) |
| Loss per share | |||
| Basic and diluted loss per share (pence) | (3.23) | (9.61) | (5.53) |
| 30 Jun 26£'000 source | 31 Dec 25£'000 source | 31 Dec 24£'000 source | |
|---|---|---|---|
| Non-current assets | |||
| Investments | – | - | 3,241 |
| Intangible exploration and evaluation assets | 3,525 | 3,405 | - |
| Property, plant and equipment | 59 | 139 | 7 |
| Total non-current assets | 3,584 | 3,544 | 3,248 |
| Current assets | |||
| Trade and other receivables | 238 | 76 | 62 |
| Inventories | 915 | 17 | - |
| Cash and cash equivalents | 131 | 64 | 57 |
| Total current assets | 1,284 | 157 | 119 |
| Total assets | 4,868 | 3,701 | 3,367 |
| Equity and liabilities | |||
| Share capital | 11,753 | 11,006 | 11,006 |
| Share premium | 4,446 | 2,753 | 2,753 |
| Share based compensation reserve | 2,573 | 2,482 | 2,482 |
| Interest in shares in EBT | (1,409) | (839) | (839) |
| Translation reserve | (620) | (656) | - |
| Accumulated losses | (16,218) | (13,647) | (14,543) |
| Convertible loan notes - equity component | 100 | 15 | 15 |
| Merger relief reserve | 1,200 | 1,200 | 1,200 |
| Total equity | 1,825 | 2,314 | 2,074 |
| Current liabilities | |||
| Trade and other payables | 692 | 560 | 466 |
| Provision for loss | – | 161 | 161 |
| Deferred consideration | 435 | - | - |
| Borrowings | 706 | 666 | 666 |
| Derivative liability | 715 | - | - |
| Total current liabilities | 2,548 | 1,387 | 1,293 |
| Non-current liabilities | |||
| Borrowings | 495 | - | - |
| Total non-current liabilities | 495 | - | - |
| Total liabilities | 3,043 | - | - |
| Total equity and liabilities | 4,868 | 3,701 | 3,367 |
| UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY | |||
| FOR THE SIX MONTHS ENDED 30 JUNE 2026 | |||
| £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 | |||
| At 1 January 2025 | (13,647) | – | – |
| Loss for the period | (698) | – | – |
| Other comprehensive income | - | – | – |
| Transactions with owners | |||
| Share-based compensation | - | – | – |
| Issue of new shares | - | – | – |
| At 30 June 2025 | (14,345) | – | – |
| At 1 January 2026 | (15,650) | – | – |
| Loss for the period | (568) | – | – |
| Other comprehensive loss | - | – | – |
| Transactions with owners | |||
| Share-based compensation | - | – | – |
| Issue of new shares | - | – | – |
| Issue of convertible loan notes | - | – | – |
| Conversion of convertible loan notes | - | – | – |
| At 30 June 2026 | (16,218) | – | – |
| 30 Jun 26£'000 source | 31 Dec 25£'000 source | 30 Jun 25£'000 source | 31 Dec 24£'000 source | |
|---|---|---|---|---|
| Non-current assets | ||||
| Investments | – | - | – | 3,241 |
| Intangible exploration and evaluation assets | 3,525 | 3,405 | 3,467 | - |
| Property, plant and equipment | 59 | 139 | 65 | 7 |
| Total non-current assets | 3,584 | 3,544 | 3,532 | 3,248 |
| Current assets | ||||
| Trade and other receivables | 238 | 76 | 212 | 62 |
| Inventories | 915 | 17 | 411 | - |
| Cash and cash equivalents | 131 | 64 | 126 | 57 |
| Total current assets | 1,284 | 157 | 749 | 119 |
| Total assets | 4,868 | 3,701 | 4,281 | 3,367 |
| Equity and liabilities | ||||
| Share capital | 11,753 | 11,006 | 11,411 | 11,006 |
| Share premium | 4,446 | 2,753 | 3,950 | 2,753 |
| Share based compensation reserve | 2,573 | 2,482 | 2,571 | 2,482 |
| Interest in shares in EBT | (1,409) | (839) | (1,398) | (839) |
| Translation reserve | (620) | (656) | (660) | - |
| Accumulated losses | (16,218) | (13,647) | (15,650) | (14,543) |
| Convertible loan notes - equity component | 100 | 15 | - | 15 |
| Merger relief reserve | 1,200 | 1,200 | 1,200 | 1,200 |
| Total equity | 1,825 | 2,314 | 1,424 | 2,074 |
| Current liabilities | ||||
| Trade and other payables | 692 | 560 | 1,001 | 466 |
| Provision for loss | – | 161 | – | 161 |
| Deferred consideration | 435 | - | 262 | - |
| Borrowings | 706 | 666 | 529 | 666 |
| Derivative liability | 715 | - | 208 | - |
| Total current liabilities | 2,548 | 1,387 | 2,000 | 1,293 |
| Non-current liabilities | ||||
| Borrowings | 495 | - | 857 | - |
| Total non-current liabilities | 495 | - | 857 | - |
| Total liabilities | 3,043 | - | 2,857 | - |
| Total equity and liabilities | 4,868 | 3,701 | 4,281 | 3,367 |
| UNAUDITED CONDENSED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY | ||||
| FOR THE SIX MONTHS ENDED 30 JUNE 2026 | ||||
| £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 £'000 | ||||
| At 1 January 2025 | (13,647) | – | 2,314 | – |
| Loss for the period | (698) | – | (698) | – |
| Other comprehensive income | - | – | 11 | – |
| Transactions with owners | ||||
| Share-based compensation | - | – | 30 | – |
| Issue of new shares | - | – | 140 | – |
| At 30 June 2025 | (14,345) | – | 1,797 | – |
| At 1 January 2026 | (15,650) | – | 1,424 | – |
| Loss for the period | (568) | – | (568) | – |
| Other comprehensive loss | - | – | 40 | – |
| Transactions with owners | ||||
| Share-based compensation | - | – | 2 | – |
| Issue of new shares | - | – | 427 | – |
| Issue of convertible loan notes | - | – | 500 | – |
| Conversion of convertible loan notes | - | – | - | – |
| At 30 June 2026 | (16,218) | – | 1,825 | – |
| FY 25£'000 source | FY 24£'000 source | |
|---|---|---|
| Cash flow from operating activities | ||
| Loss after tax | (1,617) | (1,399) |
| Adjustments for | ||
| Depreciation | 24 | 1 |
| Share-based payment expense | 40 | 40 |
| Liabilities settled by issue of shares | 95 | 95 |
| Interest expense | 59 | 59 |
| Interest income | - | - |
| Provision for / (release of) loss | 161 | 161 |
| Cost of share issue | (35) | (35) |
| Gain on disposal of Net Smelter Royalty | (200) | (200) |
| Foreign exchange (gains)/losses | (3) | – |
| Gain on fair valued financial instruments | - | - |
| Gains on disposal of property plant and equipment | (10) | - |
| Operating loss before working capital changes | (1,483) | (1,278) |
| Changes in working capital | ||
| (Increase) in inventories | (17) | - |
| (Increase) in trade & other receivables | 250 | 156 |
| Increase in trade & other payables | 108 | 142 |
| Net cash outflows from operating activities | (1,142) | (980) |
| Cash flow from investing activities | ||
| Purchase of plant and equipment | (7) | (1) |
| Proceeds from disposal of plant and equipment | 231 | - |
| Capitalised E&E expenditure | (112) | - |
| Net cash from / (used in) investing activities | 112 | (1) |
| Cash flow from financing activities | ||
| Proceeds from borrowings | 181 | 181 |
| Loan repayment | - | - |
| Issue of PIK bonds | - | - |
| Proceeds from issue of loan notes | 785 | 785 |
| Net proceeds from director loans | - | - |
| Interest paid | (31) | (31) |
| Cash proceeds from issue of shares | 86 | 86 |
| Net cash flow from financing activities | 1,021 | 1,021 |
| Net (decrease) / increase in cash & cash equivalents | (9) | 40 |
| Cash & cash equivalents at beginning of the year | 73 | 17 |
| Cash and cash equivalents at end of the year | 64 | 57 |
| H1 26£'000 source | H2 25£'000 calc. | H1 25£'000 source | |
|---|---|---|---|
| Cash flow from operating activities | |||
| Loss before tax | (568) | – | (698) |
| Adjustments for | |||
| Depreciation | 3 | 3 | 21 |
| Share-based payment expense | 2 | 10 | 30 |
| Interest expense | 93 | 19 | 40 |
| Foreign exchange losses | 45 | – | - |
| Shares issued as repayment of loan | - | – | (24) |
| Loss on fair valued financial instruments | 151 | – | - |
| Costs settled by the issue of shares | 26 | – | - |
| Operating loss before working capital changes | (248) | (852) | (631) |
| Changes in working capital | |||
| (Increase) in inventories | (504) | (17) | - |
| (Increase) in trade & other receivables | (26) | 307 | (57) |
| Increase / (decrease) in trade & other payables | (138) | (201) | 309 |
| Net cash outflows from operating activities | (916) | (763) | (379) |
| Cash flow from investing activities | |||
| Capitalised E&E expenditure | (58) | (61) | (51) |
| Purchase of PPE | (1) | – | - |
| Net cash used in investing activities | (59) | – | (51) |
| Cash flow from financing activities | |||
| Net proceeds from issue of convertible loan notes | 500 | – | - |
| Proceeds from the issue of convertible bonds | 100 | – | 273 |
| Redemption of convertible bonds | (95) | – | - |
| Proceeds from issue of shares | 346 | – | 140 |
| Advances received | 153 | – | - |
| Interest paid | (25) | (31) | - |
| Net cash flow from financing activities | 979 | 608 | 413 |
| Net increase/(decrease) in cash & cash equivalents | 4 | 8 | (17) |
| Cash & cash equivalents at beginning of the period | 126 | – | 64 |
| Cash & cash equivalents at end of the period | 131 | – | 47 |
| LTM Jun 26 | FY 25 | FY 24 | |
|---|---|---|---|
| Revenue to operating profit | |||
| Revenue | 1.4 | 0.1 | 0.0 |
| Gross profit | 0.5 | 0.0 | – |
| Operating profit | (1.5) | (1.8) | (1.6) |
| Share-based payments | 0.1 | 0.1 | 0.0 |
| Operating profit to net income | |||
| Fair value gains / losses | – | 0.0 | – |
| Finance costs | (0.3) | (0.3) | (0.1) |
| Profit before tax | (1.9) | (2.0) | (1.6) |
| Net income (owners) | (1.9) | (2.0) | (1.6) |
| Per share | |||
| EPS basic | (12.8p) | (15.1p) | (14.3p) |
| EPS diluted | (12.8p) | (15.1p) | (14.3p) |
| H1 26 | vs H1 25 | H2 25 | H1 25 | |
|---|---|---|---|---|
| Revenue to operating profit | ||||
| Revenue | 1.3 | n/m | 0.1 | 0.0 |
| Gross profit | 0.5 | n/m | 0.0 | 0.0 |
| Operating profit | (0.3) | n/m | (1.1) | (0.7) |
| Share-based payments | (0.0) | n/m | 0.1 | (0.0) |
| Operating profit to net income | ||||
| Fair value gains / losses | (0.2) | – | – | – |
| Finance costs | (0.1) | n/m | (0.2) | (0.0) |
| Profit before tax | (0.6) | n/m | (1.3) | (0.7) |
| Net income (owners) | (0.6) | n/m | (1.3) | (0.7) |
| Per share | ||||
| EPS basic | (3.2p) | – | (9.6p) | (5.5p) |
| EPS diluted | (3.2p) | – | (9.6p) | (5.5p) |
| 30 Jun 26 | 31 Dec 25 | 31 Dec 24 | |
|---|---|---|---|
| Non-current assets | |||
| Other intangibles | 3.5 | 3.5 | 3.4 |
| Property, plant & equipment | 0.1 | 0.1 | 0.1 |
| Non-current assets | 3.6 | 3.5 | 3.5 |
| Current assets | |||
| Inventories | 0.9 | 0.4 | 0.0 |
| Trade receivables | 0.2 | 0.2 | 0.1 |
| Cash | 0.1 | 0.1 | 0.1 |
| Current assets | 1.3 | 0.7 | 0.2 |
| Total assets | 4.9 | 4.3 | 3.7 |
| Current liabilities | |||
| Trade payables | 0.7 | 1.0 | 0.6 |
| Borrowings, current | 0.7 | 0.5 | 0.7 |
| Current liabilities | 2.5 | 2.0 | 1.4 |
| Non-current liabilities | |||
| Borrowings, non-current | 0.5 | 0.9 | – |
| Deferred consideration | 0.4 | 0.3 | – |
| Non-current liabilities | 0.5 | 0.9 | – |
| Total liabilities | 3.0 | 2.9 | – |
| Equity | |||
| Total equity | 1.8 | 1.4 | 2.3 |
| 30 Jun 26 | 31 Dec 25 | 31 Dec 24 | |
|---|---|---|---|
| Non-current assets | |||
| Other intangibles | 3.5 | 3.5 | 3.4 |
| Property, plant & equipment | 0.1 | 0.1 | 0.1 |
| Non-current assets | 3.6 | 3.5 | 3.5 |
| Current assets | |||
| Inventories | 0.9 | 0.4 | 0.0 |
| Trade receivables | 0.2 | 0.2 | 0.1 |
| Cash | 0.1 | 0.1 | 0.1 |
| Current assets | 1.3 | 0.7 | 0.2 |
| Total assets | 4.9 | 4.3 | 3.7 |
| Current liabilities | |||
| Trade payables | 0.7 | 1.0 | 0.6 |
| Borrowings, current | 0.7 | 0.5 | 0.7 |
| Current liabilities | 2.5 | 2.0 | 1.4 |
| Non-current liabilities | |||
| Borrowings, non-current | 0.5 | 0.9 | – |
| Deferred consideration | 0.4 | 0.3 | – |
| Non-current liabilities | 0.5 | 0.9 | – |
| Total liabilities | 3.0 | 2.9 | – |
| Equity | |||
| Total equity | 1.8 | 1.4 | 2.3 |
Read automatically from each results announcement. Check the source before relying on a figure.
Company filings. Not investment advice.